Overweight or obesity Trials in Beijing, China
Conditions / Overweight or obesity / Beijing, China
Overweight or obesity has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05881837 | Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes | COMPLETED | PHASE2 |
| NCT06948435 | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1 | RECRUITING | — |
| NCT05869903 | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06830343 | The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity | RECRUITING | PHASE1 |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight | RECRUITING | — |
| NCT07274137 | A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE） | NOT_YET_RECRUITING | PHASE3 |
| NCT04440345 | Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects | COMPLETED | PHASE1/PHASE2 |
| NCT06649045 | A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06732960 | A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients | COMPLETED | PHASE2 |
| NCT06621316 | A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |